Microbix Biosystems Inc. (TSE:MBX – Get Free Report) passed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of C$0.37 and traded as high as C$0.44. Microbix Biosystems shares last traded at C$0.43, with a volume of 358,656 shares traded.
Microbix Biosystems Price Performance
The stock has a market cap of C$71.08 million, a price-to-earnings ratio of 13.00 and a beta of 0.34. The company’s 50-day moving average is C$0.37 and its 200-day moving average is C$0.35. The company has a quick ratio of 5.57, a current ratio of 6.62 and a debt-to-equity ratio of 22.68.
Microbix Biosystems Company Profile
Microbix Biosystems Inc, a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products.
Further Reading
- Five stocks we like better than Microbix Biosystems
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Oracle Announces Game-Changing News for the AI Industry
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Netflix Adds 19 Million Subscribers, Growth Is Far From Over
- How to Invest in Biotech Stocks
- Tempus AI: A Game-Changer in AI-Powered Healthcare
Receive News & Ratings for Microbix Biosystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microbix Biosystems and related companies with MarketBeat.com's FREE daily email newsletter.
